{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T17:11:35Z","timestamp":1758042695520,"version":"3.44.0"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bone"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.bone.2020.115515","type":"journal-article","created":{"date-parts":[[2020,6,30]],"date-time":"2020-06-30T20:00:35Z","timestamp":1593547235000},"page":"115515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Fractures in children and adolescents living with perinatally acquired HIV"],"prefix":"10.1016","volume":"139","author":[{"given":"Denise L.","family":"Jacobson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wendy","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohan","family":"Hazra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean","family":"Brummel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitchell E.","family":"Geffner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kunjal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Borkowsky","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiajia","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janet S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ayesha","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linda A.","family":"DiMeglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"17","key":"10.1016\/j.bone.2020.115515_bb0005","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/QAD.0b013e32835a9b80","article-title":"Bone mineral density in children and adolescents with perinatal HIV infection","volume":"27","author":"DiMeglio","year":"2013","journal-title":"AIDS"},{"issue":"3","key":"10.1016\/j.bone.2020.115515_bb0015","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/01.mpg.0000174468.75219.30","article-title":"Predictors of bone mineral density in human immunodeficiency virus-1 infected children","volume":"41","author":"Jacobson","year":"2005","journal-title":"J. Pediatr. Gastroenterol. Nutr."},{"key":"10.1016\/j.bone.2020.115515_bb0020","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1146\/annurev.med.050108.151127","article-title":"Growing up with HIV: children, adolescents, and young adults with perinatally acquired HIV infection","volume":"61","author":"Hazra","year":"2010","journal-title":"Annu. Rev. Med."},{"issue":"5","key":"10.1016\/j.bone.2020.115515_bb0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/QAD.0b013e328336095d","article-title":"Total body and spinal bone mineral density across Tanner stage in perinatally HIV-infected and uninfected children and youth in PACTG 1045","volume":"24","author":"Jacobson","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/j.bone.2020.115515_bb0030","doi-asserted-by":"crossref","unstructured":"Arpadi, S. Shiau, R. Strehlau, F. Patel, N. Mbete, D.J. McMahon, J.J. Kaufman, A. Coovadia, L. Kuhn, M.T. Yin, Efavirenz is associated with higher bone mass in South African children with HIV, AIDS. 30(16) (2016) 2459\u20132467.","DOI":"10.1097\/QAD.0000000000001204"},{"issue":"4","key":"10.1016\/j.bone.2020.115515_bb0035","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/hiv.12418","article-title":"Adverse bone health and abnormal bone turnover among perinatally HIV-infected Asian adolescents with virological suppression","volume":"18","author":"Sudjaritruk","year":"2017","journal-title":"HIV Med."},{"issue":"5","key":"10.1016\/j.bone.2020.115515_bb0040","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"12","key":"10.1016\/j.bone.2020.115515_bb0045","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"McComsey","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"17","key":"10.1016\/j.bone.2020.115515_bb0050","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1097\/QAD.0000000000001995","article-title":"Women have enhanced bone loss associated with phosphaturia and CD4+ cell restoration during initial antiretroviral therapy","volume":"32","author":"Kalayjian","year":"2018","journal-title":"AIDS"},{"issue":"12","key":"10.1016\/j.bone.2020.115515_bb0055","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/jc.2007-1660","article-title":"Clinical review #: low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis","volume":"92","author":"Bolland","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.bone.2020.115515_bb0060","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/COH.0000000000000275","article-title":"Does systemic inflammation and immune activation contribute to fracture risk in HIV?","volume":"11","author":"McGinty","year":"2016","journal-title":"Curr. Opin. HIV AIDS"},{"issue":"4","key":"10.1016\/j.bone.2020.115515_bb0065","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1111\/acel.12308","article-title":"The HIV proteins Tat and Nef promote human bone marrow mesenchymal stem cell senescence and alter osteoblastic differentiation","volume":"14","author":"Beaupere","year":"2015","journal-title":"Aging Cell"},{"issue":"1","key":"10.1016\/j.bone.2020.115515_bb0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/QAI.0000000000001467","article-title":"Associations of low vitamin D and elevated parathyroid hormone concentrations with bone mineral density in perinatally HIV-infected children","volume":"76","author":"Jacobson","year":"2017","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"10","key":"10.1016\/j.bone.2020.115515_bb0075","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1097\/QAD.0000000000001493","article-title":"An increased rate of fracture occurs a decade earlier in HIV+ compared with HIV - men","volume":"31","author":"Gonciulea","year":"2017","journal-title":"AIDS."},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0017217","article-title":"Increased risk of fragility fractures among HIV infected compared to uninfected male veterans","volume":"6","author":"Womack","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.bone.2020.115515_bb0085","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"issue":"5","key":"10.1016\/j.bone.2020.115515_bb0090","first-page":"247","article-title":"The hidden burden of fractures in people living with HIV","volume":"2","author":"Premaor","year":"2018","journal-title":"J. Bone Miner. Res. Plus"},{"issue":"7","key":"10.1016\/j.bone.2020.115515_bb0095","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","article-title":"Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents","volume":"26","author":"Bedimo","year":"2012","journal-title":"AIDS"},{"issue":"10","key":"10.1016\/j.bone.2020.115515_bb0100","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/cix167","article-title":"Antiretrovirals, fractures, and osteonecrosis in a large international HIV cohort","volume":"64","author":"Borges","year":"2017","journal-title":"Clin. Infect. Dis."},{"issue":"3","key":"10.1016\/j.bone.2020.115515_bb0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1089\/aid.2011.0064","article-title":"Fracture risk by HIV infection status in perinatally HIV-exposed children","volume":"28","author":"Siberry","year":"2012","journal-title":"AIDS Res. Hum. Retrovir."},{"issue":"12","key":"10.1016\/j.bone.2020.115515_bb0110","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1093\/cid\/civ687","article-title":"Changing trends in complications and mortality rates among US youth and young adults with HIV infection in the era of combination antiretroviral therapy","volume":"61","author":"Mirani","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1097\/QAI.0b013e318215c7b1","article-title":"Antiretroviral treatment of US children with perinatally acquired HIV infection: temporal changes in therapy between 1991 and 2009 and predictors of immunologic and virologic outcomes","volume":"57","author":"Van Dyke","year":"2011","journal-title":"J. Acquir. Immune Defic. Syndr."},{"year":"2001","series-title":"Body Composition Comparison Data for Children, Baylor College of Medicine","author":"Ellis","key":"10.1016\/j.bone.2020.115515_bb0120"},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0125","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.jocd.2014.01.004","article-title":"Fracture prediction and the definition of osteoporosis in children and adolescents: the ISCD 2013 Pediatric Official Positions","volume":"17","author":"Bishop","year":"2014","journal-title":"J. Clin. Densitom."},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0130","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy X-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J. Clin. Densitom."},{"key":"10.1016\/j.bone.2020.115515_bb0135","first-page":"1","article-title":"CDC growth charts: United States","volume":"314","author":"Kuczmarski","year":"2000","journal-title":"Adv. Data Vital Health Stat."},{"issue":"7","key":"10.1016\/j.bone.2020.115515_bb0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/INF.0b013e31819ca49a","article-title":"Incidence of persistent renal dysfunction in human immunodeficiency virus-infected children: associations with the use of antiretrovirals, and other nephrotoxic medications and risk factors","volume":"28","author":"Andiman","year":"2009","journal-title":"Pediatr. Infect. Dis. J."},{"issue":"12","key":"10.1016\/j.bone.2020.115515_bb0145","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.2105\/AJPH.74.12.1340","article-title":"The incidence of injuries among 87,000 Massachusetts children and adolescents: results of the 1980\u201381 Statewide Childhood Injury Prevention Program Surveillance System","volume":"74","author":"Gallagher","year":"1984","journal-title":"Am. J. Public Health"},{"issue":"12","key":"10.1016\/j.bone.2020.115515_bb0150","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1359\/jbmr.040902","article-title":"Epidemiology of childhood fractures in Britain: a study using the general practice research database","volume":"19","author":"Cooper","year":"2004","journal-title":"J. Bone Miner. Res."},{"issue":"6","key":"10.1016\/j.bone.2020.115515_bb0155","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1093\/cid\/civ437","article-title":"Lower newborn bone mineral content associated with maternal use of tenofovir disoproxil fumarate during pregnancy","volume":"61","author":"Siberry","year":"2015","journal-title":"Clin. Infect. Dis."},{"issue":"6","key":"10.1016\/j.bone.2020.115515_bb0160","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1542\/peds.108.6.1287","volume":"108","author":"Miller","year":"2001","journal-title":"Pediatrics"},{"issue":"3","key":"10.1016\/j.bone.2020.115515_bb0165","doi-asserted-by":"crossref","first-page":"558","DOI":"10.2310\/JIM.0b013e318280a835","article-title":"The association between fracture rates and neighborhood characteristics in Washington, DC, children","volume":"61","author":"Ryan","year":"2013","journal-title":"J. Investig. Med."},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0170","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/01202412-199704000-00002","article-title":"Epidemiology of children's fractures","volume":"6","author":"Landin","year":"1997","journal-title":"J. Pediatr. Orthop. B"},{"issue":"3","key":"10.1016\/j.bone.2020.115515_bb0175","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-2525","article-title":"Tenofovir disoproxil fumarate and an optimized background regimen of antiretroviral agents as salvage therapy: impact on bone mineral density in HIV-infected children","volume":"118","author":"Gafni","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/j.bone.2020.115515_bb0180","unstructured":"M.G. Garcia, U. Larrinaga-Torrontegui, E. Eduardo Martinez, U. Lertxundi, I. Palacios-Zabalza, C. Aguirre, Fractures related to tenofovir: a case\/noncase study in the European Pharmacovigilance Database, Am. J. Ther. 8(10) (2018)."},{"issue":"6","key":"10.1016\/j.bone.2020.115515_bb0185","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/15284336.2016.1243363","article-title":"Systematic review of renal and bone safety of the antiretroviral regimen efavirenz, emtricitabine, and tenofovir disoproxil fumarate in patients with HIV infection","volume":"17","author":"Bedimo","year":"2016","journal-title":"HIV Clin. Trials"},{"issue":"2","key":"10.1016\/j.bone.2020.115515_bb0190","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1097\/QAI.0000000000001903","article-title":"Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: a case-control study nested within the French hospital database on HIV (FHDH-ANRS CO4)","volume":"80","author":"Costagliola","year":"2019","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.bone.2020.115515_bb0195","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(15)00348-5","article-title":"Switching from tenofovir disoproxil fumarate to tenofovir alafenamide in antiretroviral regimens for virologically suppressed adults with HIV-1 infection: a randomised, active-controlled, multicentre, open-label, phase 3, non-inferiority study","volume":"16","author":"Mills","year":"2016","journal-title":"Lancet Infect. Dis."},{"issue":"3","key":"10.1016\/j.bone.2020.115515_bb0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1080\/15284336.2017.1291867","volume":"18","author":"Post","year":"2017","journal-title":"HIV Clin. Trials"},{"issue":"12","key":"10.1016\/j.bone.2020.115515_bb0205","doi-asserted-by":"crossref","first-page":"e561","DOI":"10.1016\/S2352-3018(16)30121-7","article-title":"Safety, efficacy, and pharmacokinetics of a single-tablet regimen containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide in treatment-naive, HIV-infected adolescents: a single-arm, open-label trial","volume":"3","author":"Gaur","year":"2016","journal-title":"Lancet HIV"},{"issue":"1","key":"10.1016\/j.bone.2020.115515_bb0210","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/17453671003628780","article-title":"Epidemiology of fractures in children and adolescents","volume":"81","author":"Hedstrom","year":"2010","journal-title":"Acta Orthop."},{"issue":"656","key":"10.1016\/j.bone.2020.115515_bb0215","first-page":"1","article-title":"Pattern of fractures across pediatric age groups: analysis of individual and lifestyle factors","volume":"10","author":"Valerio","year":"2010","journal-title":"BMC Public Health"},{"issue":"4","key":"10.1016\/j.bone.2020.115515_bb0220","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jana.2018.03.004","article-title":"Relationships between physical activity and bone density in people living with HIV: results from the SATURN-HIV study","volume":"29","author":"Perazzo","year":"2018","journal-title":"J. Assoc. Nurses AIDS Care"}],"container-title":["Bone"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220302957?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S8756328220302957?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T17:49:44Z","timestamp":1757612984000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S8756328220302957"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":44,"alternative-id":["S8756328220302957"],"URL":"https:\/\/doi.org\/10.1016\/j.bone.2020.115515","relation":{},"ISSN":["8756-3282"],"issn-type":[{"type":"print","value":"8756-3282"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fractures in children and adolescents living with perinatally acquired HIV","name":"articletitle","label":"Article Title"},{"value":"Bone","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bone.2020.115515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115515"}}